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Oculopharyngeal  muscular  dystrophy  (OPMD)  is  a  genetic
disease  with  a  predominantly  autosomal  dominant  pattern,
linked  to  the  PABPN1  gene.  OPMD  progresses  with  a  clinical
picture  of  progressive  ptosis,  dysphagia,  and  weakness  of
the  proximal  muscles  of  the  limbs.1
The  disease  usually  begins  in  the  ﬁfth  or  sixth  decade
of  life.  In  its  recessive  form,  symptoms  have  a  later  onset
are  usually  mild;  in  these  cases  the  diagnosis  becomes  more
difﬁcult,  and  there  may  be  confusion  with  symptoms  of  other
diseases  associated  with  aging.2
A  Canadian  study  estimated  the  prevalence  of  OPMD  at
1:1000.3 Most  cases  reported  in  the  literature  present  a fam-
ily  history  of  neuromuscular  disease,  but  there  are  rare  cases
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reserved.here  it  was  not  possible  to  establish  this  association,  and
he  appropriate  explanation  is  the  occurrence  of  mutation.1
he  literature  describes  oculopharyngeal  distal  myopathy
OPDM)  as  a  controversial  entity:  it  is  considered  by  some
s  a  distinct  disorder  from  OPMD,  and  by  others  as  a  variant
f  this  disease.4
Thevathasan  et  al.  report  that  early-onset  ophthalmo-
aresis  is  a  frequent  ﬁnding  in  OPDM.  The  involvement  of
imb  muscles  initially  occurs  distally,  and  tibialis  anterior
uscle  and  intrinsic  muscles  of  the  hands  are  the  most
ommonly  affected.  Lu  et  al.  add  that,  in  OPMD,  the  symp-
omatology  begins  most  often  in  young  adults,  with  a  severe
acial  muscle  weakness.
To  carry  out  a  proper  investigation  of  OPMD  and  its
ifferentiation  from  a  variety  of  differential  diagnoses
mitochondrial  disorders,  Nonaka  myopathy,  and  OPDM,
mong  others),  it  is  critical  to  perform  tests  such  as  anti-
ody  anti-acetylcholine  receptor  dosage,  serum  lactate
urve,  electromyography,  muscle  biopsy,  and  genetic  testing
valuation.4The  histopathological  ﬁndings  of  both  diseases  (OPMD  and
PDM)  include  nonspeciﬁc  dystrophic  myopathic  abnormal-
ties  and  the  presence  of  vacuoles  and  tubular-ﬁlamentous
rgia Cérvico-Facial. Published by Elsevier Editora Ltda. All rights
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The  patient  was  treated  with  speech  therapy  for  degluti-
tion,  and  botulinum  toxin  was  applied  in  his  salivary  glands
to  reduce  saliva  production.ARTICLE
 
ntramuscular  nuclear  inclusions;  the  latter  is  larger  in  cases
f  OPDM  (>8  nm).5
Genetic  tests  showed  that  in  patients  with  OPDM,  a
epeating  pattern  of  base  pairs  (‘‘GCG’’)  in  PABPN1  gene
oes  not  occur  --  a  ﬁnding  present  in  cases  of  OPMD.4
Among  the  muscle  changes  detected,  dysphagia  is  the
ost  concerning  symptom,  because  it  evidences  a  progres-
ive  weakening  of  the  esophageal  and  pharyngeal  muscles,
hich  are  responsible  for  the  swallowing  process.  The
egree  of  dysphagia  presented  by  the  patient  is  an  important
rognostic  factor  of  the  disease,  as  these  patients  progress
o  malnutrition.6
The  curative  treatment  of  OPMD  is  still  unknown.  How-
ver,  medical  or  surgical  treatments  can  be  carried  out  in
rder  to  improve  the  patient’s  quality  of  life.
In  the  case  of  dysphagia,  it  is  feasible  to  intro-
uce  changes  in  food  consistency,  as  well  as  facilitating
aneuvers  and  speech  therapy  for  swallowing.  When  the
stablished  therapy  no  longer  appears  to  be  effective,  or  in
ace  of  a  signiﬁcant  weight  loss  or  recurrent  aspiration  pneu-
onia,  there  may  be  an  indication  for  surgical  treatment,
.g.,  cricopharyngeal  myotomy  or  even  gastrostomy.6
This  study  aimed  to  report  a  clinical  case  of  a  patient
ith  signiﬁcant  muscle  disorder  and  with  a  deltoid  muscle
iopsy  compatible  with  OPMD.  However,  despite  the  diag-
ostic  efforts,  it  was  not  possible  to  distinguish  this  disease
rom  OPDM.
ase report
RS,  62-years  old  retired  male,  was  assessed  at  this  service
ecause  of  complaints  of  long-time  progressive  dysphagia.
The  patient  reported  the  onset  of  progressive  symmet-
ical  ptosis  at  the  age  of  36  years.  He  was  then  evaluated
nd  diagnosed  with  neuromuscular  disease  compatible  with
PMD  or  OPDM  (presence  of  rimmed  vacuoles  at  the  deltoid
uscle  biopsy  material).
The  patient  was  referred  to  the  Department  of  Ophthal-
ology  for  surgery,  aiming  at  a  frontal  suspension  of  his  eyes,
n  order  to  facilitate  the  vision.
At  52  years  of  age,  the  patient  reported  the  onset  of  dys-
hagia  (choking  on  solid  foods,  need  to  clear  his  throat,  and
uid  intake  after  food  intake).  He  also  mentioned  increas-
ng  difﬁculty  in  speaking  and  moving  the  muscles  of  the
ace  and  eyes,  and  reported  the  progression  of  symptoms
Figs.  1  and  2).
At  age  57  years,  the  patient  had  trouble  raising  his  right
rm  and  also  opening  his  right  hand,  which  was  in  a  ‘‘claw’’
osition,  in  addition  to  a  general  weakness  of  his  legs  that
esulted  in  several  falls  (Fig.  3).
At  that  time,  the  patient  said  that  his  lips  began  to  ‘‘fall’’
sic),  along  with  possible  episodes  of  urinary  incontinence.
Since  the  onset  of  symptoms,  the  patient  reported  a
eight  loss  of  around  13  kg  and  two  episodes  of  pneumonia.
Family  history  revealed  that  the  patient  has  seven  sib-
ings,  two  of  whom  have  bilateral  ptosis  (one  sister  with
nset  of  ptosis  at  age  69  years  and  one  brother  with  onset
t  age  74  years).  One  of  his  four  children  has  bilateral  ptosis,
hich  began  at  age  37  years.
The  patient  was  assessed  regarding  his  dysphagia  com-
laints.Figure  1  Patient’s  front  view.
Swallowing  endoscopy  with  the  use  of  various  food  types
nd  amounts  (liquid,  paste,  and  solid)  detected  a  moderate
ropharyngeal  dysphagia  with  no  visualization  of  pene-
ration  or  food  aspiration.  Drooling  caused  by  difﬁculty
wallowing  was  also  noted.Figure  2  Patient’s  lateral  view.
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The  use  of  botulinum  toxin  in  this  patient’s  salivary  glands
aimed  to  decrease  saliva  production,  resulting  in  less  volume
for  swallowing.  To  date,  this  patient  is  still  being  followed-
up  for  his  dysphagia.Figure  3  Claw  hand.
Discussion
Despite  controversies  in  the  literature,  van  der  Sluijs  et  al.
reported  in  their  article  the  main  clinical  features  of  OPMD7:
a  slowly  progressive  bilateral  ptosis,  weakness  of  proximal
limbs,  and  progressive  dysphagia.
These  authors  report  that  the  abovementioned  ﬁndings
have  a  late  onset;  while  in  OPDM,  the  onset  of  symptoms
occurs  earlier  (between  15  and  20  years  of  age),  with  an
initial  manifestation  of  tibialis  anterior  muscle  weakness,
or  of  bilateral  ptosis.7
They  also  report  that,  in  these  patients,  an  intense  hypo-
tonia  of  the  muscles  of  the  face  and  of  the  extrinsic  muscles
of  the  eyes  is  noteworthy,  which  results  in  ptosis  and  limi-
tation  of  ocular  and  facial  movements,  with  a  more  severe
and  earlier  occurrence  than  in  cases  of  OPMD.7
Minami  et  al.8 discussed  case  reports  of  OPMD  with
involvement  of  distal  muscles  in  the  literature;  these
authors  reported  that  it  would  be  extremely  difﬁcult  to  dis-
tinguish  OPMD  from  OPDM  by  simply  analyzing  the  clinical
features.
In  that  study,  after  an  evaluation  of  PABPN1  gene,  the
authors  obtained  results  regarding  the  presence  of  repeti-
tions  of  the  base  pairs  ‘GCG’  present  in  OPMD.8
In  the  clinical  picture  discussed  in  the  present  study,
ptosis  started  at  a  young  age  (at  36  years  of  age).  Fur-
thermore,  the  patient  showed  muscle  alterations  in  the
face,  extrinsic  muscles  of  the  eyes,  right  hand,  and  lower
limbs.
Together  with  dysphagia,  these  signs  and  symptoms  indi-
cate  a  possible  diagnosis  of  OPDM.  However,  the  proximal
muscles  (scapular  and  pelvic  girdles)  were  affected,  which
makes  the  diagnosis  of  OPMD  possible.
A  deltoid  muscle  biopsy  allowed  detection  of  atrophic
polygonal  muscle  ﬁbers  and  of  intrasarcoplasmic  rimmed
vacuoles.  The  presence  of  rimmed  vacuoles  is  characteris-
tic  of  both  diseases;  thus,  it  is  not  possible  to  differentiate
between  OPMD  and  OPDM  (Figs.  4  and  5).
Unfortunately,  genetic  testing  to  aid  in  diagnosis  is  not
available  at  this  service.  As  already  foreseen  by  Minami
et  al.,8 it  was  not  possible  to  differentiate  these  two  dis-
eases  (OPMD  and  OPDM)  based  on  the  clinical  information
available.
F
vigure  4  Rimmed  vacuoles  at  the  deltoid  muscle  biopsy  (mod-
ﬁed Gomori  stain,  350×).
Progressive  dysphagia  is  seen  in  both  diseases,  and  it
ay  become  severe  and  cause  frequent  aspiration  pneumo-
ia.  Because  this  patient  exhibited  moderate  oropharyngeal
ysphagia  with  drooling,  the  authors  enacted  a  clinical
anagement  protocol  that  included:  speech  therapy  for
eglutition;  exercises  to  improve  oral  motor  skills;  change  in
ood  consistency;  and  chemical  xerostomia  with  botulinum
oxin  application.
To  date,  there  is  no  treatment  for  both  diseases;  thus,
herapy  should  focus  on  the  correction  of  any  deﬁcits  pre-
ented,  aiming  at  a  better  quality  of  life.
In  addition  to  improving  the  dynamics  of  deglutition,  the
ntroduction  of  speech  therapy  for  deglutition  aimed  to  cor-
ect  unwanted  postures.  Both  the  retroﬂexion  of  the  head
nd  frontal  muscle  contraction  are  known  compensatory
echanisms  for  correction  of  ptosis,  which  has  a  negative
ffect  on  swallowing,  worsening  a  pre-existing  dysphagia.  A
light  bending  of  the  head  can  improve  the  oropharyngeal
hase  of  swallowing,  reducing  the  meal  time,  the  waste,
nd  the  risk  of  aspiration.9igure  5  Presence  of  polygonal  muscular  atrophy  and  rimmed
acuoles  (hematoxylin--eosin  stain,  350×).
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onclusion
n  this  study,  the  authors  presented  and  described  a  case  of
 rare  neuromuscular  disease,  with  an  important  impact  on
he  swallowing  process.
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